Nanotechnology based drug delivery system: Current strategies and emerging therapeutic potential for medical science

T Sahu, YK Ratre, S Chauhan, L Bhaskar… - Journal of Drug Delivery …, 2021 - Elsevier
Nanotechnology or Nano medicine has been identified as the dominant and most
commercially invented technology that aims to improve the quality of health care strategies …

New developments in liposomal drug delivery

BS Pattni, VV Chupin, VP Torchilin - Chemical reviews, 2015 - ACS Publications
New Developments in Liposomal Drug Delivery | Chemical Reviews ACS ACS Publications
C&EN CAS Find my institution Log In Chemical Reviews ACS Publications. Most Trusted. Most …

Nano-and micro-based inhaled drug delivery systems for targeting alveolar macrophages

WH Lee, CY Loo, D Traini… - Expert opinion on drug …, 2015 - Taylor & Francis
Introduction: Macrophages are the most versatile cells in the hematopoietic system and are
strategically distributed in tissues to fight pathogens or other foreign particles. In the lung …

Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases

CF Anderson, ME Grimmett… - Wiley Interdisciplinary …, 2020 - Wiley Online Library
Respiratory illnesses are prevalent around the world, and inhalation‐based therapies
provide an attractive, noninvasive means of directly delivering therapeutic agents to their site …

[HTML][HTML] Challenges for pulmonary delivery of high powder doses

I Sibum, P Hagedoorn, AH de Boer, HW Frijlink… - International journal of …, 2018 - Elsevier
In recent years there is an increasing interest in the pulmonary delivery of large cohesive
powder doses, ie drugs with a low potency such as antibiotics or drugs with a high potency …

Dry powder inhalers of antitubercular drugs

N Nainwal, Y Sharma, V Jakhmola - Tuberculosis, 2022 - Elsevier
Despite advancements in the medical and pharmaceutical fields, tuberculosis remains a
major health problem globally. Patients do not widely accept the conventional approach to …

Innovative therapeutic approaches based on nanotechnology for the treatment and management of tuberculosis

P Kia, U Ruman, AR Pratiwi… - International journal of …, 2023 - Taylor & Francis
Tuberculosis (TB), derived from bacterium named Mycobacterium tuberculosis, has become
one of the worst infectious and contagious illnesses in the world after HIV/AIDS. Long-term …

Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future

P Mehta, C Bothiraja, S Kadam… - … cells, nanomedicine, and …, 2018 - Taylor & Francis
Tuberculosis (TB) is a contagious and airborne infectious disease caused by the pathogen
Mycobacterium tuberculosis (Mtb). In spite of substantial research efforts, continuous …

Dry powder inhalable formulations for anti-tubercular therapy

T Parumasivam, RYK Chang, S Abdelghany… - Advanced drug delivery …, 2016 - Elsevier
Tuberculosis (TB) is an intracellular infectious disease caused by the airborne bacterium,
Mycobacterium tuberculosis. Despite considerable research efforts, the treatment of TB …

Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis

LÁ Ibarra-Sánchez, A Gámez-Méndez… - Journal of Drug Delivery …, 2022 - Elsevier
Respiratory diseases are leading causes of death and disability in developing and
developed countries. The burden of acute and chronic respiratory diseases has been rising …